BioSyent Announces Approval of New Product
May 31, 2023 17:42 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, May 31, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its subsidiary, BioSyent Pharma Inc., has received...
BioSyent Releases Financial Results for Q1 2023
May 26, 2023 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, May 26, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months ended March 31, 2023. Key highlights...
BioSyent Declares Second Quarter 2023 Dividend
May 25, 2023 17:40 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, May 25, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly...
BioSyent Schedules Q1 2023 Earnings Release for May 26, 2023
May 18, 2023 08:30 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, May 18, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months ended March 31, 2023 on...
RADDOG™, the Robot Dog from AITX’s Subsidiary, Robotic Assistance Devices, to Appear on New FOX Reality Series ‘Stars on Mars’
May 15, 2023 08:40 ET
|
Artificial Intelligence Technology Solutions, Inc.
Detroit, Michigan, May 15, 2023 (GLOBE NEWSWIRE) -- Artificial Intelligence Technology Solutions, Inc., (the “Company”) (OTCPK:AITX), a global leader in AI-driven security and productivity solutions...
FeraMAX® Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians, Eight Years Running!
May 02, 2023 14:59 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, May 02, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that FeraMAX® is the #1 recommended iron supplement brand in Canada, based...
FeraMAXᴹᴰ est le 1er choix de supplément de fer recommandé par les pharmaciens et les médecins canadiens, pour la huitième année consécutive!
May 02, 2023 14:59 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, 02 mai 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (« BioSyent », Bourse de croissance TSX : RX) a le plaisir d’annoncer que FeraMAXMD est le 1er choix de marque de supplément de...
BioSyent to Present at 2023 Bloom Burton & Co. Healthcare Investor Conference
April 18, 2023 09:15 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, April 18, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming 2023 Bloom Burton & Co....
Data Analytics Outsourcing Market is estimated to be US$ 19.35 billion by 2030 with a CAGR of 22.1% during the forecast period – BY PMI
April 05, 2023 19:05 ET
|
PMI
Covina, April 05, 2023 (GLOBE NEWSWIRE) -- “According to the latest research study, the demand of Data Analytics Outsourcing Market accounted for US$ 2.6 billion in 2020 and is estimated to be US$...
BioSyent Announces Grant of Restricted Share Units
March 31, 2023 17:42 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, March 31, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent” or the “Company”, TSX Venture: RX) announces that its Board of Directors has approved a grant of 72,020...